Cel-Sci
CVM
#9814
Rank
โ‚ฌ40.11 M
Marketcap
5,02ย โ‚ฌ
Share price
-1.67%
Change (1 day)
-72.95%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2025 (TTM): -10,44ย โ‚ฌ

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -9,56ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,43ย โ‚ฌ an increase over its 2023 EPS that were of -0,62ย โ‚ฌ.

EPS history for Cel-Sci from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-10,44ย โ‚ฌ2305.64%
2024-0,43ย โ‚ฌ-30.14%
2023-0,62ย โ‚ฌ-16.09%
2022-0,74ย โ‚ฌ-3.33%
2021-0,77ย โ‚ฌ9.76%
2020-0,70ย โ‚ฌ15.49%
2019-0,60ย โ‚ฌ-62.03%
2018-1,59ย โ‚ฌ2.19%
2017-1,56ย โ‚ฌ-22.78%
2016-2,02ย โ‚ฌ-77.45%
2015-8,94ย โ‚ฌ-13.14%
2014-10,29ย โ‚ฌ61.33%
2013-6,38ย โ‚ฌ-57.14%
2012-14,89ย โ‚ฌ-45.31%
2011-27,22ย โ‚ฌ-420%
20108,51ย โ‚ฌ-112.9%
2009-65,93ย โ‚ฌ342.86%
2008-14,89ย โ‚ฌ-30%
2007-21,27ย โ‚ฌ-0%
2006-21,27ย โ‚ฌ150%
2005-8,51ย โ‚ฌ-0%
2004-8,51ย โ‚ฌ-75%
2003-34,03ย โ‚ฌ-54.29%
2002-74,44ย โ‚ฌ-31.37%
2001-108,46ย โ‚ฌ15.91%
2000-93,58ย โ‚ฌ-14.58%
1999-109,55ย โ‚ฌ-29.73%
1998-155,90ย โ‚ฌ-26%
1997-210,67ย โ‚ฌ-13.79%
1996-244,38ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Curis
CRIS
-3,12ย โ‚ฌ-67.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-0,04254ย โ‚ฌ-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
11,08ย โ‚ฌ-215.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,51ย โ‚ฌ-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ-105.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
8,88ย โ‚ฌ-192.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
1,20ย โ‚ฌ-112.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-65,26ย โ‚ฌ 582.47%๐Ÿ‡บ๐Ÿ‡ธ USA